[Piroxicam in the treatment of rheumatoid arthritis]. 1988

Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin

Open and double blind trials in 80 patients with proved and definite rheumatoid arthritis have shown that piroxicam possesses marked analgesic and antiinflammatory action, is well tolerated producing a therapeutic effect only at high doses exceeding the mean ones recommended in the literature.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010894 Piroxicam A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. CP-16171,Feldene,CP 16171,CP16171
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1981, European journal of rheumatology and inflammation,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1983, Casopis lekaru ceskych,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1987, European journal of rheumatology and inflammation,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1983, Current medical research and opinion,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
April 1992, The Journal of rheumatology,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1993, Clinical therapeutics,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
February 1985, Seminars in arthritis and rheumatism,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1988, The Journal of rheumatology,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
December 1983, Bangladesh Medical Research Council bulletin,
Iu V Murav'ev, and A I Mamistova, and Ia A Sigidin
January 1988, European journal of clinical pharmacology,
Copied contents to your clipboard!